Markets Businessinsider

Published September 23, 2026

Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD ...

Read the full story at Markets Businessinsider

(NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) ("Optimi " or the "Company "), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug.